These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3286516)

  • 21. Ciprofloxacin in severe infections.
    Aswapokee N; Pruksachatvuthi S; Aswapokee P
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin: an overview and prospective appraisal.
    Neu HC
    Am J Med; 1987 Apr; 82(4A):395-404. PubMed ID: 3578329
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases.
    Esposito S; Galante D; Barba D; Bianchi W; Gagliardi R; Giusti R
    Infection; 1988; 16 Suppl 1():S57-61. PubMed ID: 3286517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cutaneous infections. Worldwide experience with ciprofloxacin.
    Parish LC; Witkowski JA; Jungkind DL; Asper RF
    Int J Dermatol; 1988 Mar; 27(2):131-3. PubMed ID: 3360559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of skin and soft tissue infections with imipenem/cilastatin.
    Fass RJ; Freimer EH; McCloskey RV
    Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
    Greenberg RN; Kennedy DJ; Reilly PM; Luppen KL; Weinandt WJ; Bollinger MR; Aguirre F; Kodesch F; Saeed AM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):151-5. PubMed ID: 3566245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of gastrointestinal infections with ciprofloxacin].
    Ippolito A; La Gioia G; Matarrese M; Resta F; Angelini P; Ruffo F
    Minerva Med; 1991 Apr; 82(4):181-7. PubMed ID: 2017314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.
    Nichols RL; Smith JW; Gentry LO; Gezon J; Campbell T; Sokol P; Williams RR
    South Med J; 1997 Dec; 90(12):1193-200. PubMed ID: 9404904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections.
    LeFrock JL; Johnson ES; Smith LG; Rosenberg E
    Am J Med; 1985 Nov; 79(5B):122-5. PubMed ID: 3907339
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
    Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 33. Cefadroxil in the treatment of skin and soft tissue infections.
    Ballantyne F
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():143-7. PubMed ID: 6754687
    [No Abstract]   [Full Text] [Related]  

  • 34. Ciprofloxacin treatment of acute infections in immunocompromised host.
    Nemes G; Heuser Y; Stolle D; Piroth HD; Nemes P
    J Chemother; 1989 Jul; 1(4 Suppl):722-3. PubMed ID: 16312607
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
    Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
    Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical efficacy of a novel antimicrobial drug combination containing ciprofloxacin and tinidazole in the treatment of patients with skin and soft tissue infections].
    Iakovlev VP; Blatun LA; Terekhova RP
    Antibiot Khimioter; 2005; 50(2-3):48-51. PubMed ID: 16308940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin. Best use of this new broad-spectrum antibiotic.
    Fass RJ
    Postgrad Med; 1990 Jun; 87(8):117-22, 124, 127-31. PubMed ID: 2189125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin: in vitro, experimental, and clinical evaluation.
    Thadepalli H; Bansal MB; Rao B; See R; Chuah SK; Marshall R; Dhawan VK
    Rev Infect Dis; 1988; 10(3):505-15. PubMed ID: 3393781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ciprofloxacin in the treatment of various bacterial infections.
    Phillips HL; Nolen TM; Hutchison J
    Ala Med; 1989 Apr; 58(10):28-32. PubMed ID: 2729030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ; Plouffe JF; Russell JA
    Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.